Effectiveness of Self-myofascial Release Combined With Biofeedback and Electrical Stimulation for the Management of Myofascial Pelvic Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Myofascial Pelvic Pain
- Sponsor
- Zhongda Hospital
- Enrollment
- 82
- Locations
- 1
- Primary Endpoint
- The change of pain intensity
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Myofascial pelvic pain (MFPP) caused by myofascial trigger points (MTrPs) is a major contributor of female chronic pelvic pain. However, the effect of the patient's self-myofascial release (SMFR) is not clear. Current study is to investigate the effect of SMFR combined with biofeedback and electrical stimulation (BES) therapy compared with BES alone in patients with MFPP.
Detailed Description
68 patients was enrolled and randomly allocated into two groups: BES-SMFR group (n=34) and BES group (n=34). Every patient received 4 weeks treatment, and was evaluated at baseline (T0), 4-week post-intervention (T4) and 12-week follow-up (T12). The primary outcome was pain intensity. The secondary outcomes were degree in activation of MTrPs, surface electromyography (sEMG) levels, and Patient Global Impression of Improvement (PGI-I).
Investigators
Yang Shen
Vice President
Zhongda Hospital
Eligibility Criteria
Inclusion Criteria
- •age between 18 and 70 years;
- •presence of persistent chronic pelvic pain ≥ 4 points on a 10 points numeric rating scale for at least 3 months;
- •at least one active MTrP in one of muscle group including obturator internus, levator ani, piriformis, coccygeus on pelvic examination.
Exclusion Criteria
- •diseases of the urinary, genital, colorectal systems;
- •prolapse of the pelvic organ;
- •a history of pelvic rehabilitation within the 3 months prior to study;
- •psychiatric disorders;
- •breastfeeding.
Outcomes
Primary Outcomes
The change of pain intensity
Time Frame: Up to 12 weeks
Pain intensity was calculated by using the visual numeric rating scale (NRS), which is a 11-point rating scale ranging from "0" (no pain) to "10" (worst pain imaginable) . For each patient, the NRS referred to pain elicited while palpating bilaterally each PFM groups and was averaged pain across all the muscles. Upon palpation, the patient was asked to place in a resting, semi-recumbent position with legs supported by pillow to prevent excessive tension in the PFMs.
Secondary Outcomes
- The degree in activation of MTrPs(Up to 12 weeks)
- The score of Patient Global Impression of Improvement (PGI-I)(Up to 12 weeks)
- Surface electromyography (sEMG) levels of the PFMs(Up to 12 weeks)